|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's range||3.1800 - 3.2400|
|52-week range||1.1000 - 5.3500|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
OncoCyte Corporation ( NASDAQ:OCX ) shareholders have seen the share price descend 23% over the month. Despite this...
Investors need to pay close attention to OncoCyte (OCX) stock based on the movements in the options market lately.
OncoCyte (OCX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.